The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded a $749,566 Project Grant to Yale University under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 4-year research project to evaluate the real-world impact of the Inflation Reduction Act's $35 monthly insulin cap for Medicare beneficiaries. The study aims to examine changes in patient out-of-pocket costs, insulin utilization, clinical outcomes, and sociodemographic disparities in diabetes care before and after the policy's implementation. By leveraging comprehensive nationwide claims data, the researchers will provide crucial evidence to inform future healthcare policy decisions on prescription drug affordability and improving diabetes outcomes. The grant period runs from January 1, 2025 through November 30, 2028.